PRICKLE2-AS1

gene
On this page

Summary

PRICKLE2-AS1 (PRICKLE2 antisense RNA 1, HGNC:40916) is a long non-coding RNA gene on chromosome 3p14.1.

At a glance

  • Clinical variants (ClinVar): 77 total

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:40916
Approved symbolPRICKLE2-AS1
NamePRICKLE2 antisense RNA 1
Location3p14.1
Locus typeRNA, long non-coding
StatusApproved
Ensembl geneENSG00000241572
Entrez100652759
RNAcentralURS000075DA3C — lncRNA, 6521 nt, 1 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 0

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

None — 0 exons

Expression profiles

Bgee: expression breadth broad, 86 present calls, max score 84.18.

Top tissues by expression

86 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047384.18gold quality
hindlimb stylopod muscleUBERON:000425268.31gold quality
ganglionic eminenceUBERON:000402363.97gold quality
right testisUBERON:000453461.62gold quality
left testisUBERON:000453361.37gold quality
testisUBERON:000047360.89gold quality
ventricular zoneUBERON:000305360.09gold quality
cortex of kidneyUBERON:000122556.62gold quality
smooth muscle tissueUBERON:000113556.29gold quality
kidneyUBERON:000211356.10gold quality
prefrontal cortexUBERON:000045155.96gold quality
stromal cell of endometriumCL:000225555.47gold quality
islet of LangerhansUBERON:000000655.36gold quality
endocervixUBERON:000045854.02gold quality
endometriumUBERON:000129553.53gold quality
heart left ventricleUBERON:000208452.95gold quality
liverUBERON:000210752.73silver quality
muscle of legUBERON:000138352.62gold quality
monocyteCL:000057652.21gold quality
gastrocnemiusUBERON:000138852.08gold quality
bloodUBERON:000017851.66silver quality
heartUBERON:000094850.13gold quality
pancreasUBERON:000126449.36gold quality
adult mammalian kidneyUBERON:000008249.04gold quality
right lobe of liverUBERON:000111448.90silver quality
multicellular organismUBERON:000046848.74gold quality
right lungUBERON:000216748.01gold quality
tibial arteryUBERON:000761047.70gold quality
stomachUBERON:000094547.31gold quality
left coronary arteryUBERON:000162647.25gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.00

Regulation

Is transcription factor: no

Cross-species orthologs

0 orthologs

Protein

Protein identifiers

Canonical reviewed UniProt: None (reviewed: )

All UniProt accessions (0):

RefSeq proteins (0): (*=MANE)

Domains & families (InterPro)

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 5 (showing top): chr3p14, CBX5_TARGET_GENES, DESCARTES_MAIN_FETAL_PHOTORECEPTOR_CELLS, DESCARTES_FETAL_ADRENAL_SLC26A4_PAEP_POSITIVE_CELLS, DESCARTES_FETAL_EYE_PHOTORECEPTOR_CELLS

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (0):

Protein interactions and networks

STRING

0 interactions, top by confidence (×1000):

IntAct

0 interactions, top by confidence:

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

77 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance53
Likely benign22
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

176 predictions. Top by Δscore:

VariantEffectΔscore
3:64099923:GGCCT:Gacceptor_loss1.0000
3:64099925:CCT:Cacceptor_loss1.0000
3:64099927:T:Aacceptor_loss1.0000
3:64099086:T:TAdonor_gain0.9900
3:64099921:GAGGC:Gacceptor_gain0.9900
3:64099922:AGGC:Aacceptor_gain0.9900
3:64099923:GGC:Gacceptor_gain0.9900
3:64099924:GC:Gacceptor_gain0.9900
3:64099925:CC:Cacceptor_gain0.9900
3:64099926:C:CCacceptor_gain0.9900
3:64099063:A:ACdonor_gain0.9800
3:64099064:C:CCdonor_gain0.9800
3:64099077:T:TAdonor_gain0.9700
3:64099109:C:CTdonor_gain0.9700
3:64099926:C:Tacceptor_gain0.9700
3:64099105:TCTGC:Tdonor_gain0.9400
3:64099106:CTGCC:Cdonor_gain0.9400
3:64099385:T:Adonor_gain0.9400
3:64099107:TGC:Tdonor_gain0.9100
3:64102708:T:TAdonor_gain0.8400
3:64099448:T:Cdonor_gain0.8200
3:64099007:CATT:Cdonor_gain0.7700
3:64099110:C:CTdonor_gain0.7600
3:64099008:A:Cdonor_gain0.7500
3:64099002:CT:Cdonor_gain0.7300
3:64099003:TT:Tdonor_gain0.7300
3:64099004:TT:Tdonor_gain0.7300
3:64099064:CAGTT:Cdonor_gain0.7200
3:64099064:CA:Cdonor_gain0.7000
3:64099675:T:TAdonor_gain0.6800

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000059461 (3:64080805 G>A), RS1000090309 (3:64081100 T>C), RS1000218064 (3:64094345 T>C), RS1000364628 (3:64086498 C>A), RS1000378311 (3:64068641 T>G), RS1000462173 (3:64100663 T>C), RS1000554087 (3:64095701 C>A,G,T), RS1000634797 (3:64095381 T>C), RS1000640976 (3:64087760 T>C), RS1000727933 (3:64097460 T>A), RS1000785307 (3:64090855 C>T), RS1000900408 (3:64090976 C>T), RS1000973198 (3:64085055 C>G,T), RS1001065730 (3:64079449 A>G), RS1001095167 (3:64079663 C>T)

Disease associations

OMIM: gene `` | disease phenotypes: MIM:254800

GenCC curated gene-disease

Mondo (2): myoclonic epilepsy (MONDO:0100577), progressive myoclonus epilepsy (MONDO:0020074)

Orphanet (3): Progressive myoclonic epilepsy type 5 (Orphanet:402082), Progressive myoclonic epilepsy type 1 (Orphanet:308), Progressive myoclonic epilepsy (Orphanet:98261)

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

MeSH disease descriptors (1)

DescriptorNameTree numbers
D020191Myoclonic Epilepsies, ProgressiveC10.228.140.490.375.130.650; C10.228.140.490.493.063.650

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 0 entries

CTD chemical–gene interactions

5 total (human), top 5 by PubMed support.

ChemicalActions (top 5)PubMed papers
dimethylselenideincreases expression, increases oxidation1
fipronilaffects cotreatment, decreases expression1
DEETaffects cotreatment, decreases expression1
Ozoneincreases expression, increases oxidation1
Hydroxyl Radicalincreases expression, increases oxidation1

Clinical trials (associated diseases)

3 trials via MONDO — disease-level, not drug-specific.

TrialPhaseStatusTitle
NCT00006191Not specifiedCOMPLETEDEffect of Levetiracetam on Brain Excitability
NCT06593951Not specifiedRECRUITINGRegistry and Natural History Study for Progressive Myoclonus Epilepsy Type 1 (EPM1)
NCT06923241Not specifiedCOMPLETEDNutri-score Labelling in a UK Restaurant Setting: a Randomised Control Trial